| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0147237897640499 | 0.30319305 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0147237897640499 | 0.30634231 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0147237897640499 | 0.32938539 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0147237897640499 | 0.2365469 |
| NSC 244404 | Null | 0.0147237897640499 | 0.44923778 |
| NSC 303861 | L-Cysteine analog | 0.0147237897640499 | 0.47554487 |
| NSC 614887 | Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) | 0.0147237897640499 | 0.4594518 |
| NSC 617394 | Null | 0.0147237897640499 | 0.52255914 |
| NSC 649312 | Null | 0.0147237897640499 | 0.33601128 |
| NSC 651605 | Null | 0.0147237897640499 | 0.27820311 |